{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:46:49Z","timestamp":1755218809097,"version":"3.43.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.fjurol.2025.102908","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T12:02:36Z","timestamp":1747310556000},"page":"102908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing radio-hormone therapy to radical prostatectomy for patients with high-risk localized prostate cancer in an Afro-Caribbean population"],"prefix":"10.1016","volume":"35","author":[{"given":"Simon","family":"Bellucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Roumegu\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Tosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaut","family":"Long-Depaquit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Sacino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Brureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.fjurol.2025.102908_bib0155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.fjurol.2025.102908_bib0160","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"10.1016\/j.fjurol.2025.102908_bib0165","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2009.27.2153","article-title":"Chlordecone exposure and risk of prostate cancer","volume":"28","author":"Multigner","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.fjurol.2025.102908_bib0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euf.2019.06.004","article-title":"Biochemical recurrence in prostate cancer: the European Association of Urology Prostate Cancer Guidelines Panel Recommendations","volume":"6","author":"Van den Broeck","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2025.102908_bib0180","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.fjurol.2025.102908_bib0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2025.102908_bib0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12957-020-01824-9","article-title":"The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis","volume":"18","author":"Wang","year":"2020","journal-title":"World J Surg Oncol"},{"issue":"5","key":"10.1016\/j.fjurol.2025.102908_bib0195","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.eururo.2020.01.033","article-title":"Benefits and risks of primary treatments for high-risk localized and locally advanced prostate cancer: an international multidisciplinary systematic review","volume":"77","author":"Moris","year":"2020","journal-title":"Eur Urol"},{"issue":"16","key":"10.1016\/j.fjurol.2025.102908_bib0200","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.purol.2022.07.147","article-title":"French AFU Cancer Committee Guidelines 2022\u20132024: prostate cancer\u00a0\u2013\u00a0recurrence treatment and metastatic disease","volume":"32","author":"Ploussard","year":"2022","journal-title":"Prog Urol"},{"issue":"4","key":"10.1016\/j.fjurol.2025.102908_bib0205","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy for prostate cancer: the Phoenix consensus conference","volume":"65","author":"Pollack","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.fjurol.2025.102908_bib0210","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1038\/s41467-023-43726-w","article-title":"Prostate cancer genetic risk and associated aggressive disease in men of African ancestry","volume":"14","author":"Soh","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.fjurol.2025.102908_bib0215","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ijc.32287","article-title":"Endocrine disrupting-chemicals and biochemical recurrence of prostate cancer after prostatectomy: a cohort study in Guadeloupe (French West Indies)","volume":"146","author":"Brureau","year":"2020","journal-title":"Int J Cancer"},{"issue":"13","key":"10.1016\/j.fjurol.2025.102908_bib0220","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/cncr.25900","article-title":"Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer","volume":"117","author":"Boorjian","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.fjurol.2025.102908_bib0225","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/2090598X.2022.2026010","article-title":"Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: an updated systematic review and meta-analysis","volume":"20","author":"Aydh","year":"2022","journal-title":"Arab J Urol"},{"issue":"5\u20136","key":"10.1016\/j.fjurol.2025.102908_bib0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/21681805.2018.1520295","article-title":"SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer","volume":"52","author":"Stranne","year":"2018","journal-title":"Scand J Urol"},{"issue":"10","key":"10.1016\/j.fjurol.2025.102908_bib0235","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.purol.2022.04.014","article-title":"High risk localized and locally advanced prostate cancer: long-term oncological outcomes after prostatectomy","volume":"32","author":"Miro-Padovani","year":"2022","journal-title":"Prog Urol"},{"issue":"9","key":"10.1016\/j.fjurol.2025.102908_bib0240","doi-asserted-by":"crossref","first-page":"574.e11","DOI":"10.1016\/j.urolonc.2019.06.005","article-title":"Comparative effectiveness of treatments for high-risk prostate cancer patients","volume":"37","author":"Jayadevappa","year":"2019","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.fjurol.2025.102908_bib0245","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/pros.24253","article-title":"Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients","volume":"82","author":"Hoeh","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.fjurol.2025.102908_bib0250","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ijrobp.2010.07.1975","article-title":"Long-term results after high-dose radiotherapy and adjuvant hormones in prostate cancer: how curable is high-risk disease?","volume":"81","author":"Zapatero","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.fjurol.2025.102908_bib0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2017.05.055","article-title":"Survival and complications following surgery and radiation for localized prostate cancer: an international collaborative review","volume":"73","author":"Wallis","year":"2018","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2025.102908_bib0260","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12894-023-01350-2","article-title":"Pliensiri prediction of biochemical recurrence after laparoscopic radical prostatectomy","volume":"23","author":"Bejrananda","year":"2023","journal-title":"BMC Urol"},{"issue":"4","key":"10.1016\/j.fjurol.2025.102908_bib0265","doi-asserted-by":"crossref","first-page":"163e7","DOI":"10.1016\/j.urolonc.2014.11.018","article-title":"Natural history of surgically treated high-risk prostate cancer","volume":"33","author":"Briganti","year":"2015","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.fjurol.2025.102908_bib0270","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12894-016-0146-6","article-title":"Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer","volume":"16","author":"Beauval","year":"2016","journal-title":"BMC Urol"},{"issue":"10","key":"10.1016\/j.fjurol.2025.102908_bib0275","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/MNM.0000000000000888","article-title":"68Ga-PSMA PET\/CT and PET\/MRI in high-risk prostate cancer patients","volume":"39","author":"Sanli","year":"2018","journal-title":"Nucl Med Commun"},{"issue":"10231","key":"10.1016\/j.fjurol.2025.102908_bib0280","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.fjurol.2025.102908_bib0285","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2024.10.006","article-title":"Pelvic lymph node dissection in prostate cancer: update from a randomized clinical trial of limited versus extended dissection","volume":"87","author":"Touijer","year":"2025","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2025.102908_bib0290","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","article-title":"The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review","volume":"72","author":"Fossati","year":"2017","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.fjurol.2025.102908_bib0295","first-page":"165","article-title":"[Prostate cancer in Guadeloupe (French West Indies): incidence, mortality and clinicopathological features]","volume":"96","author":"Brureau","year":"2009","journal-title":"Bull Cancer"},{"issue":"15","key":"10.1016\/j.fjurol.2025.102908_bib0300","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.purol.2022.07.148","article-title":"French AFU Cancer Committee Guidelines\u00a0\u2013\u00a0update 2022\u20132024: prostate cancer\u00a0\u2013\u00a0diagnosis and management of localised disease","volume":"32","author":"Ploussard","year":"2022","journal-title":"Prog Urol"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393025000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393025000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:51:09Z","timestamp":1754481069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393025000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2950393025000555"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2025.102908","relation":{},"ISSN":["2950-3930"],"issn-type":[{"type":"print","value":"2950-3930"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing radio-hormone therapy to radical prostatectomy for patients with high-risk localized prostate cancer in an Afro-Caribbean population","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2025.102908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102908"}}